HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
Clinical trial NCT07685535 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07685535
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-06-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.